BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
NO Bill Number, Cancer Research. Lobbied to support cancer research.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CAROZZA | — |
| RICHARD THOMPSON | — |
Trade (domestic/foreign) TRD
Korea Sprycel Reimbursement. Lobbied to acquire a transparent and consistent reimbursement procedure. KOREA FTA. Provided updates to U.S. Government Staff on FTA. Intellectual Property Rights. Provided primer to Congressional staff on IPR issues of importance to BMS. Investments in Greece.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID E WARR | — |
Taxation/Internal Revenue Code TAX
S. 2886 and H.R. 6049, Extension of the Research & Development Tax Credit. Lobbied in favor of the extension.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN RYAN | — |
Copyright/Patent/Trademark CPT
CPTS. 1145, Patent Reform Act of 2007. Lobbied Members of Congress to improve provisions related to inequitable conduct and damages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CAROZZA | — |
| CHRISTOPHER PERNIE | — |
Health Issues HCR
H.R. 5629/S. 1695, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 1424, The Paul Wellstone Mental Health and Addiction Equity Act. Lobbied Members of Congress in support of mental health parity and against increased Medicaid rebates. S. 2731/ H.R. 5501, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008. Lobbied Members of Congress in support of reauthorization of the Presidents Emergency Program for AIDS Relief. H.R. 5629/ S. 1695, Pathway for Biosimilars Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity. H.R. 3610, Food and Drug Import Safety Act of 2007. Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act. Lobbied for passage of bill H.R. 5839, Safeguarding Americas Pharmaceuticals Act of 2008. Lobbied for passage of bill. S. 2320 NO Bill Number, Pharmaceuticals in The environment. Lobbied to educate Members of Congress on the issue of pharmaceuticals in the environment. No Bill Number, Labor, HHS Appropriations Bill. Lobbied to ensure patient access to HIV/AIDS medicines through ADAP.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CAROZZA | — |
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
| RICHARD THOMPSON | — |
Medicare/Medicaid MMM
S. 3101, Medicare Improvements for Patients and Providers Act of 2008. Lobby to maintain the current rebate percentage. S. 2320, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bill. No Bill Number, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CAROZZA | — |
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
Consumer Issues/Safety/Products CSP
S. 2928, BPA-Free Kids Act of 2008. Lobbied to inform Members of Congress on the safety of materials used to line cans of infant formula.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CAROZZA | — |
Clean Air and Water (quality) CAW
NO Bill Number, Pharmaceuticals in the environment. Lobbied to educate Members of Congress on the issue of pharmaceuticals in the environment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL CAROZZA | — |
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.